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It has long been possible to measure the phenotype of antibody responses (antigen-specific titers) through 
conventional serological assays (e.g., ELISA). In contrast, the ability to measure the genotype of antibody 
responses has only recently become possible through the advent of high-throughput antibody repertoire 
sequencing (Ig-seq), which provides quantitative molecular information on clonal expansion, diversity and 
somatic hypermutation. However, Ig-seq is compromised by the presence of bias and errors introduced during 
library preparation and sequencing and thus prevent reliable immunological conclusions from being made. By 
using synthetic antibody spike-in genes, we determined that Ig-seq data overestimated antibody diversity 
measurements by up to 5000-fold and was less than 60% accurate in clonal frequency measurements.  
 
In order to overcome the widespread inaccuracies in Ig-seq, we developed a method known as molecular 
amplification fingerprinting (MAF). This consists of stepwise incorporation of unique molecular identifiers (UID), 
which starts with tagging first-strand cDNA during reverse transcription with a reverse-UID (RID), thus providing 
a unique tag to each transcript. Importantly MAF continues by tagging each DNA-RID molecule during multiplex-
PCR amplification with a forward-UID (FID). This fingerprint of amplification for each molecule allowed us to 
implement an algorithm to normalize multiplex-amplification bias effects. We used several bioinformatic steps for 
error correction, this resulted in nearly absolute 
(98%) or absolute (100%) correction of intraclonal 
and clonal variants, respectively (Fig. 1a, b). 
Furthermore, by tagging molecules during 
amplification we were able to develop a novel 
algorithm for bias correction, this resulted in 98% 
accuracy of antibody clonal frequencies (Fig. 6c, 
d).  
 
In order to probe the relationship between 
antibody genotype and phenotype, we have 
performed extensive in vivo experiments from 
immunized mice. Specifically, we modulated titer 
(phenotype) by varying the number of 
immunizations (boosts) and in parallel performed 
MAF Ig-seq to assess genotype through a series 
of quantitative metrics. These metrics describe 
clonal selection, expansion, and somatic 
hypermutation. Importantly, we also used different 
protein antigens, this allowed us to determine how 
epitope complexity impacted the genotype of 
antibody repertoires. Finally, by applying 
multivariate modeling using MAF-corrected data, 
we were able to predict the immune status of 
individual antibody clones. This extensive 
systems-based analysis demonstrates how 
accurate Ig-seq provides insight on the genotype 










































































MAF-based: R2 = 0.98
Figure 1. MAF error and bias correction validation. (a) 
Phylogenetic trees before and after MAF-error correction 
of intraclonal variants for a single spike-in example clone. 
(b) Phylogenetic trees before and after MAF-error 
correction of clonal variants (CDR3 a.a.) for a single spike-
in example clone. (c) Correlation of uncorrected spike-in 
clonal frequencies from multiplex-PCR versus singleplex-
PCR results in an R2 = 0.42. (d) Correlation of MAF bias 
corrected spike-in clonal frequencies from multiplex-PCR 
versus singleplex-PCR results in a significantly improved 
R2 = 0.98.  
